Navigation Links
VBI awarded $27 million from NIH to support infectious disease research
Date:10/5/2009

dle the designated bacterial data in the context of infectious diseases the change in scale of data acquisition and analysis is astonishing and we are poised to learn a lot."

The new contract covers the development of two web-based resources for biomedical research. The first part of the project supports the development of the Pathogen Portal for the entire BRC program. The Pathogen Portal will serve as an informatics coordinating center and gateway for the four newly established BRCs. This publicly accessible web portal will provide general information about the BRC program, serve as a gateway to the individual BRC web sites, and provide a central data repository and analysis resource for all selected NIAID category A-C priority pathogens supported by the individual BRCs. Said Sobral, "In addition to its centralized coordination role, the Pathogen Portal project will work closely with other external partners, for example NIAID's Clinical Proteomics Centers for Infectious Diseases and Biodefense, among others, which is making candidate protein biomarkers linked to disease available to the wider scientific community."

The second part of the project supports the development of the PATRIC 2.0 BRC. In June 2004, NIAID awarded CIG a five-year, $10.3 million contract to establish a multi-organism relational database for infectious disease research that focused on biodefense and emerging infectious diseases. The PathoSystems Resource Integration Center (PATRIC; see http://patric.vbi.vt.edu/) was created to serve as a comprehensive web-based resource for an important subset of pathogens from the set of selected NIAID category A-C priority pathogens. The work supported by the PATRIC 2.0 award, which will span all bacterial species in the selected NIAID category A-C priority pathogens list, will consolidate earlier PATRIC work, as well as the work of other BRC systems that handled bacterial data, into PATRIC 2.0.
'/>"/>

Contact: Barry Whyte
whyte@vbi.vt.edu
540-231-1767
Virginia Tech
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. UNC awarded Cancer Genome Atlas grant
2. 2 neuroscientists from Cold Spring Harbor Laboratory awarded transformative NIH grants
3. IOF-AMGEN Health Professional Awareness Grants awarded at Beijing conference
4. Prestigious $4.9 million NIH grant awarded to Case Western Reserve for colon cancer research
5. UA awarded $4.35 million to study Earths critical zone
6. Researcher awarded $1.2 million grant to study centrosomes and cilia
7. Barrow scientist awarded $400,000 grant to study cell associated with intuition and autism
8. IGC scientist awarded prestigious European Research Council Starting grant
9. LSUHSCs Bazan awarded ARRA grant to preserve vision
10. UTSA psychologist awarded $1 million for memory research
11. LSUHSCs Kolls awarded $1.8 million to improve vaccine strategies for P. carinii pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... BOSTON , July 23, 2014 ... and threat detection, announced today it has been named ... . The Market Guide replaces Gartner,s well-known Magic Quadrant ... Gartner categorized BioCatch as one of several vendors to ... biometric analysis will become a standard feature of at ...
(Date:7/23/2014)... around the world by 2050, according to one of ... Change (IPCC), may be advantageous to the physiology and ... of forage plants such as Stylosanthes capitata Vogel ... countries such as Brazil., The conclusion is from a ... Biology at the Ribeiro Preto Faculty of Philosophy, Sciences ...
(Date:7/23/2014)... play an increasingly important role in carbon and nutrient ... expand, according to research published this week in the ... , University of British Columbia researchers plumbed the depth ... chart how microbial community metabolism changes as oxygen minimum ... picture of how SUP05 a bacterial group related ...
Breaking Biology News(10 mins):BioCatch Featured in Gartner's 2014 Online Fraud Detection Market Guide 2BioCatch Featured in Gartner's 2014 Online Fraud Detection Market Guide 3An increase in temperature by 2050 may be advantageous to the growth of forage plants 2An increase in temperature by 2050 may be advantageous to the growth of forage plants 3An increase in temperature by 2050 may be advantageous to the growth of forage plants 4Research charts the ecological impact of microbial respiration in the oxygen-starved ocean 2
... University of Illinois animal sciences professor Harris Lewin ... Agriculture. He shares the prize with James R. Cook, ... are awarded each year, with recipients in agriculture, chemistry, ... selected Lewin for his "highly significant discoveries" in the ...
... Hospital of Philadelphia has announced the establishment of the ... A ceremony on Feb. 15 at the Hospital,s Ruth ... first holder of the chair, pediatric immunologist Jordan S. ... allow Dr. Orange to break new ground in his ...
... clues as to the habitats in which they are ... implications for predicting the effects of climate change on ... kingdom. Applying a method previously only used to ... scientists from the University of Cambridge can now determine ...
Cached Biology News:Illinois professor awarded 2011 Wolf Prize in Agriculture 2Modell Chair in Pediatric Immunology established 2Insects hold atomic clues about the type of habitats in which they live 2
(Date:7/23/2014)... (PRWEB) July 23, 2014 Shimadzu ... LC/MS amino acid analysis system developed jointly with ... UF-Amino Station can analyze 38 amino acids in ... UF-Amino Station achieves high-speed analysis utilizing a fast ... LCMS-2020 provides accurate analytical results even under conditions ...
(Date:7/23/2014)... 23, 2014 StemGenex® , the ... the US aimed at improving the lives of patients ... study for Parkinson’s disease. StemGenex believes that a ... therapy are paramount when providing care to patients with ... stem cell therapy accessible to the millions of individuals ...
(Date:7/23/2014)... regulated information -- UCB today announced an important advance ... topline results from the latest Phase 3 study ... evaluate the efficacy and safety of brivaracetam ... to placebo, as adjunctive treatment in adult focal ... despite treatment with one or two concomitant antiepileptic ...
(Date:7/23/2014)... China Cord Blood Corporation (NYSE: CO ) ... of cord blood collection, laboratory testing, hematopoietic stem cell processing, and ... healthcare company catering to the mother and child segment, today announced ... the PRC, Singapore , Hong Kong ... , the Philippines and Malaysia ...
Breaking Biology Technology:Shimadzu's New UF-Amino Station Provides High-Speed, Multi-Component Analysis of Amino Acids in Food & Beverage and Pharmaceutical Testing 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 2China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 3China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 4
... Par,Pharmaceutical Companies, Inc. (NYSE: PRX ) today ... meclizine HCl tablets immediately. At,this time, Par believes it ... Par marketed meclizine prior to an explosion at the ... since qualified a new API source and,received the appropriate ...
... July 9 Axendia Inc., a,trusted advisor to ... CBI Research Inc., a provider of live and,electronic ... industries, today announced that Daniel R. Matlis President ... Manufacturing Execution,Systems for Life Sciences Congress" to be ...
... RICHMOND, Va., July 9 Insmed Inc. (Nasdaq:,INSM), a ... Glover, President Insmed Therapeutics, will present at the,Collins Stewart ... 10:30 AM ET, in New York., The conference ... New,York City, from Tuesday, July 8 through Thursday, July ...
Cached Biology Technology:Par Pharmaceutical to Launch meclizine HCL Tablets 2Axendia's President to Chair 3rd Annual MES for Life Sciences Congress 2Insmed to Present at Collins Stewart Fourth Annual Growth Conference 2
Mouse monoclonal antibody raised against a partial recombinant KRT4. NCBI Entrez Gene ID = KRT4...
Mouse monoclonal antibody raised against a partial recombinant ALPK3. NCBI Entrez Gene ID = ALPK3...
... Lines ,High Quality, Functionally-Validated, Ion Channel Cell ... for having a critical role in nerve ... key function in pain, CNS and the ... been investigated in therapeutic areas, such as ...
... ,High Quality, Functionally-Validated, Ion Channel Cell Lines ... having a critical role in nerve and ... function in pain, CNS and the heart. ... investigated in therapeutic areas, such as neuropathic ...
Biology Products: